Colin Snow
Sleep problems are a common side effect of heart failure, and it is standard practice for patients to be prescribed sleeping pills when they are discharged from the hospital. However, studies have found that sleeping pills increase the risk of cardiovascular events in heart failure patients by up to eight times. Specifically, benzodiazepine hypnotics may have cardiodepressant and respiratory depressant actions, which could lead to a worse prognosis for patients with sleep disordered breathing. On the other hand, some research suggests that hypnotics are associated with a decreased risk of heart disease, with zolpidem showing a 29% reduction in risk. While sleeping pills may provide short-term relief, they can also lead to dependency, and it is important to explore alternative solutions such as self-guided digital behavioral therapy and lifestyle changes like exercise and reducing stimulants.
| Characteristics | Values |
|---|---|
| Risk of cardiovascular events in heart failure patients | Increased by 8-fold |
| Risk of or mortality from heart disease | Decreased in Asia but not in Western countries |
| Zolpidem | Decreased risk of heart disease by 29% |
| Benzodiazepines | Increased risk of heart disease by 80% |
| Cardiovascular side effects | Not reported in Tasimelteon clinical trials |
| Sleep apnea | Associated with sleeping pills but not causally related |
Explore related products
What You'll Learn
Sleeping pills and the risk of cardiovascular events
Sleep problems are a frequent side effect of heart failure, and it is common for patients to be prescribed sleeping pills when they are discharged from the hospital. However, research has shown that sleeping pills increase the risk of cardiovascular events in heart failure patients.
A study presented at the Heart Failure Congress in 2014 found that sleeping pills increased the risk of cardiovascular events in heart failure patients by eightfold. The study analyzed patients with heart failure with preserved ejection fraction (HFpEF) and those with heart failure with reduced ejection fraction (HFrEF) separately. It was found that HFpEF patients who were prescribed sleeping pills (benzodiazepine hypnotics) had an eight times greater risk of rehospitalization for heart failure or cardiovascular-related death than those who were not.
Dr. Setoguchi, the lead researcher, stated that benzodiazepine hypnotics may have cardiodepressant and respiratory depressant actions, which could worsen the prognosis for patients with sleep disordered breathing. He recommended that these patients be carefully monitored and that further investigation in larger studies is needed before advising heart failure patients to stop taking sleeping pills.
Another meta-analysis of observational studies found a decreased risk of or mortality from heart disease associated with the use of hypnotics. However, when analyzing by the type of heart disease, there was a significant relationship between hypnotic use and cardiovascular disease. Additionally, benzodiazepines were associated with an increased risk of heart disease, while zolpidem was associated with a decreased risk.
While sleeping pills may provide temporary relief from sleep disturbances, it is essential to carefully consider the potential risks, especially for individuals with heart failure or cardiovascular disease. Further research and larger studies are needed to fully understand the complex interactions between sleeping pill usage and cardiovascular events.
How Serotonin Affects Sleep and Dreams
You may want to see also
Explore related products
Benzodiazepine hypnotics and heart failure patients
Benzodiazepines are commonly prescribed hypnotics for patients with insomnia. They target the benzodiazepine sites of the γ-aminobutyric acid (GABA) type A (GABAA) receptors. By allosterically increasing the GABAA receptors' affinity for GABA, an inhibitory neurotransmitter, benzodiazepines induce hypnosis, anxiolysis, seizure suppression, muscle relaxation, and amnesia.
However, several studies have raised concerns about the safety of benzodiazepine hypnotics, particularly for patients with heart failure. One study found that benzodiazepines may have cardiodepressant and respiratory depressant actions, which could exacerbate sleep-disordered breathing and lead to a worse prognosis for heart failure patients. Another study, which examined 124,445 patients from the UK Biobank, concluded that benzodiazepine use was significantly associated with an increased risk of cardiovascular disease, heart failure, and mortality over a median follow-up period of 14.3 years.
The prognostic impact of benzodiazepines on patients with heart failure has also been observed in a historical observational cohort study. The study found that among patients with heart failure and coexisting insomnia, those receiving benzodiazepines were at a higher risk of rehospitalization for heart failure than those receiving Z-drugs (zolpidem, zopiclone, and/or eszopiclone). The benzodiazepine group also had a higher prevalence of depression and lower levels of hemoglobin, sodium, and albumin.
While benzodiazepines may improve sleep fragmentation and total nocturnal sleep time in patients with cardiac failure, the potential risks associated with their use cannot be overlooked, especially for patients with heart failure. It is crucial for medical professionals to carefully weigh the benefits and potential harms before prescribing benzodiazepines, especially for patients with cardiovascular concerns.
Combining 5-HTP and Sleeping Pills: Safe or Risky?
You may want to see also
Explore related products
Zolpidem and decreased risk of heart disease
While sleeping pills can increase the risk of cardiovascular events in heart failure patients, certain types of hypnotics may have a decreased risk of heart disease.
Zolpidem is a non-benzodiazepine hypnotic medication widely used to manage insomnia. It is associated with a decreased risk of heart disease, specifically a 29% reduction in the risk of developing or dying from heart disease. This was supported by a meta-analysis of observational epidemiological studies.
However, it is important to note that zolpidem has also been associated with an increased risk of cardiac arrhythmias, including atrial fibrillation, ventricular fibrillation, and cardiac arrest. The heightened risk of arrhythmias was observed across various demographic and comorbidity subgroups. Additionally, zolpidem-triggered atrial fibrillation has been reported in a patient with cardiomyopathy, although this is an isolated case.
The relationship between zolpidem use and heart disease is complex and requires further research. While zolpidem may offer a decreased risk of developing heart disease, it is associated with an increased risk of arrhythmias, which can have serious health implications. Healthcare practitioners should carefully consider these risks and monitor patients when prescribing zolpidem, especially those with pre-existing heart conditions or other comorbidities.
Sleeping Pills: What Do They Look Like?
You may want to see also
Explore related products
Sleep apnea and heart patients
Sleep apnea is a common breathing disorder that can increase the risk of a multitude of health conditions, including heart disease. Obstructive sleep apnea (OSA) is the most common form of sleep apnea, affecting approximately 34% of middle-aged men and 17% of middle-aged women. OSA is characterised by recurrent complete and partial upper airway obstructions, resulting in intermittent hypoxemia, autonomic fluctuation, and sleep fragmentation.
The link between sleep apnea and cardiovascular disease has been demonstrated in several studies. Untreated sleep apnea significantly increases the risk of heart arrhythmias and cardiovascular disease. Sleep apnea increases the risk of heart failure by 140%, the risk of stroke by 60%, and the risk of coronary heart disease by 30%. Patients with sleep apnea are 2-4 times more likely to develop heart arrhythmias than those without the condition.
The repetitive pauses in breathing caused by sleep apnea can stress and potentially damage the heart and the entire cardiovascular system. Sleep apnea has also been linked to increased sympathetic nervous system activity, which can induce blood vessel constriction and higher blood pressure. Treatment of sleep apnea with nasal continuous positive airway pressure (CPAP) has been shown to reduce systolic blood pressure, improve left ventricular systolic function, and increase ejection fraction.
The prevalence of OSA in patients with heart disease is high, and cardiac patients are vulnerable to OSA-related stressors and adverse cardiovascular outcomes. Despite this, OSA is often underrecognized and undertreated in cardiovascular practice. Screening for OSA is recommended in patients with resistant or poorly controlled hypertension, pulmonary hypertension, and recurrent atrial fibrillation after cardioversion or ablation. In patients with heart failure and suspected sleep-disordered breathing or excessive daytime sleepiness, a formal sleep assessment is reasonable.
Nyquil for Sleep: Safe or Not?
You may want to see also
Explore related products
Side effects of sleeping pills
Sleeping pills can cause a range of side effects, some of which can be dangerous. The side effects vary depending on the medication and the individual taking it. Some common side effects include drowsiness, dizziness, and impaired focus the next day. Other potential side effects include:
- Constipation or diarrhoea
- Muscle weakness
- Digestive problems, including gas, heartburn, and nausea
- Worsening of snoring and sleep apnea
- Memory issues and confusion
- Balance problems
- Dry mouth
- Difficulty with movement
- Burning or tingling sensation in the hands, arms, feet, or legs
- Parasomnias, such as sleepwalking or eating while asleep
- Allergic reactions
- Dependence or addiction
- Respiratory depression during sleep
- Increased risk of accidental falls
Sleeping pills can also interfere with normal breathing and be dangerous for people with certain chronic lung problems, such as asthma or COPD. Additionally, long-term use of sleeping pills can lead to drug tolerance, brain degeneration, and an increased risk of Alzheimer's disease. It is important to consult a doctor if you experience any severe or persistent side effects and to follow their recommendations for safe use and dosage.
Slim Belts: Can You Sleep With Them On?
You may want to see also
Frequently asked questions
There is no conclusive evidence that sleeping pills cause heart disease, but they are associated with an increased risk of cardiovascular events in heart failure patients. It is recommended that patients with sleep disorders or breathing difficulties be carefully monitored.
There are a few alternatives to sleeping pills that can help heart patients improve their sleep quality. These include establishing a sleep routine, such as reading a book or meditating before bed, taking a hot bath, drinking herbal tea, and exercising regularly.
Yes, sleeping pills may increase the risk of cardiovascular events in heart patients, including hospitalization or death. Additionally, patients can become dependent on sleeping medication, and side effects may negatively impact their quality of life.
If a heart patient is experiencing difficulty sleeping that is impacting their quality of life, they should consult a doctor or nurse. It is important to discuss all current medications with the healthcare provider to determine the best course of action.
